Evaxion A/S insider reports warrant holdings

Rhea-AI Filing Summary

Evaxion A/S filed an initial ownership report for its Chief Scientific Officer, detailing holdings of warrants and ordinary shares of Evaxion A/S. The filing shows direct ownership of 36,765 ordinary shares and multiple warrant series over additional ordinary shares at various exercise prices and expirations.

These warrants cover amounts such as 36,765 underlying shares at an exercise price of $0.74 expiring on December 21, 2026, and other grants with exercise prices including $0.10, $0.40, $0.75, $2.23, and $5.38 expiring on dates through 2036. One warrant position stems from a private placement that closed on December 21, 2023, and certain grants vest at a rate of 1/36 per month over 36 months from their initial exercise dates.

Insider Trade Summary

11 transactions reported

Mixed 11 txns

Insider Evaxion A/S

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Warrants — 323,641 contracts (Direct); Ordinary Shares — 36,765 shares (Direct)

Footnotes (2)

1. F1. Warrants pursuant to private placement that closed 12/21/2023.
2. F2. Vesting is 1/36 per month over 36 months from the initial exercise date indicated.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Evaxion A/S (EVAX) report in this Form 3 filing?

Evaxion A/S reports its Chief Scientific Officer’s initial ownership in company securities. The filing lists directly held ordinary shares and multiple warrant grants, each with specific exercise prices, expiration dates, and vesting terms, providing a baseline view of this insider’s equity-linked position.

How many Evaxion A/S ordinary shares are directly held according to the Form 3?

The Form 3 shows direct ownership of 36,765 ordinary shares of Evaxion A/S. This position is separate from the various warrants, which, if exercised, could convert into additional ordinary shares under the stated exercise prices and expiration schedules disclosed in the filing.

What warrant positions are disclosed for Evaxion A/S (EVAX) in this Form 3?

The filing lists several warrant series over Evaxion A/S ordinary shares. Examples include 36,765 underlying shares at $0.74 per share expiring in December 2026 and other warrants with $0.10, $0.40, $0.75, $2.23, and $5.38 exercise prices expiring through 2036.

Is any Evaxion A/S warrant position tied to a private placement?

Yes. A footnote states that one set of warrants was issued pursuant to a private placement that closed on December 21, 2023. This clarifies that those particular warrants originated from a financing transaction, rather than from standard employee or officer compensation grants.

How do vesting terms work for certain Evaxion A/S warrants in this Form 3?

A footnote explains that some warrants vest at 1/36 per month over 36 months from the initial exercise date listed. This means the right to exercise these warrants becomes available gradually, aligning vesting with the specified multi-year schedule.

Does the Evaxion A/S Form 3 show any insider buying or selling activity?

The Form 3 presents holding entries rather than new purchases or sales. It establishes the Chief Scientific Officer’s existing ownership of ordinary shares and warrants, without recording open-market buy or sell transactions in the disclosed summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 09:07 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Evaxion A/S

(Last) (First) (Middle)

DR. NEERGAARDS VEJ 5F

(Street)

HORSHOLM DK-2970

(City) (State) (Zip)

DENMARK

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Evaxion A/S [ EVAX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	36,765	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants(1)	12/21/2023	12/21/2026	Ordinary Shares	36,765	$0.74	D
Warrants	01/01/2017	12/31/2036	Ordinary Shares	1,152	$0.1	D
Warrants	01/01/2018(2)	12/31/2036	Ordinary Shares	7,092	$0.1	D
Warrants	01/01/2019(2)	12/31/2031	Ordinary Shares	10,440	$0.1	D
Warrants	01/01/2020(2)	12/31/2031	Ordinary Shares	10,692	$0.1	D
Warrants	01/01/2021(2)	12/31/2031	Ordinary Shares	45,000	$5.38	D
Warrants	01/01/2022(2)	12/31/2031	Ordinary Shares	25,000	$2.23	D
Warrants	01/01/2023(2)	12/31/2031	Ordinary Shares	12,500	$0.75	D
Warrants	01/01/2024(2)	12/31/2031	Ordinary Shares	50,000	$0.4	D
Warrants	01/01/2024(2)	12/31/2031	Ordinary Shares	125,000	$0.07	D

Explanation of Responses:

1. Warrants pursuant to private placement that closed 12/21/2023.

2. Vesting is 1/36 per month over 36 months from the initial exercise date indicated.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney. This initial holding statement has been made for Birgitte Rono using the Issuer's CIK codes to satisfy Form 3 filing requirements. An amendment will be filed for Ms. Rono upon receipt of her CIK filer codes from the SEC.

	/s/ Michael Baird, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)